Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Tumor Proteins D52 and D54 Have Opposite Effects on the Terminal Differentiation of Chondrocytes.

Ito C, Mukudai Y, Itose M, Kato K, Motohashi H, Shimane T, Kondo S, Shirota T.

Biomed Res Int. 2017;2017:6014278. doi: 10.1155/2017/6014278. Epub 2017 Jul 17.

2.

Opposite effects of tumor protein D (TPD) 52 and TPD54 on oral squamous cell carcinoma cells.

Kato K, Mukudai Y, Motohashi H, Ito C, Kamoshida S, Shimane T, Kondo S, Shirota T.

Int J Oncol. 2017 May;50(5):1634-1646. doi: 10.3892/ijo.2017.3929. Epub 2017 Mar 23.

PMID:
28339026
3.

Tumor protein D52 expression is post-transcriptionally regulated by T-cell intercellular antigen (TIA) 1 and TIA-related protein via mRNA stability.

Motohashi H, Mukudai Y, Ito C, Kato K, Shimane T, Kondo S, Shirota T.

Biochem J. 2017 May 4;474(10):1669-1687. doi: 10.1042/BCJ20160942.

PMID:
28298474
4.

Methanol and Butanol Extracts of Paeonia lutea Leaves Repress Metastasis of Squamous Cell Carcinoma.

Mukudai Y, Zhang M, Shiogama S, Kondo S, Ito C, Motohashi H, Kato K, Fujii M, Shintani S, Shigemori H, Yazawa K, Shirota T.

Evid Based Complement Alternat Med. 2016;2016:6087213. doi: 10.1155/2016/6087213. Epub 2016 May 17.

5.

Clinicopathological implications of vascular endothelial growth factor 165b expression in oral squamous cell carcinoma stroma.

Nagasaki M, Kondo S, Mukudai Y, Kamatani T, Akizuki A, Yaso A, Shimane T, Shirota T.

Oncol Rep. 2016 Jul;36(1):573-81. doi: 10.3892/or.2016.4826. Epub 2016 May 20.

PMID:
27221145
6.

A Combination of Low-Intensity Pulsed Ultrasound and Nanohydroxyapatite Concordantly Enhances Osteogenesis of Adipose-Derived Stem Cells From Buccal Fat Pad.

Nagasaki R, Mukudai Y, Yoshizawa Y, Nagasaki M, Shiogama S, Suzuki M, Kondo S, Shintani S, Shirota T.

Cell Med. 2015 Apr 22;7(3):123-31. doi: 10.3727/215517915X688057. eCollection 2015 Oct 1.

7.

Differential expression of vascular endothelial growth factor in high- and low-metastasis cell lines of salivary gland adenoid cystic carcinoma.

Kondo S, Mukudai Y, Soga D, Nishida T, Takigawa M, Shirota T.

Anticancer Res. 2014 Feb;34(2):671-7.

PMID:
24510998
8.

Potential anti-osteoporotic effects of herbal extracts on osteoclasts, osteoblasts and chondrocytes in vitro.

Mukudai Y, Kondo S, Koyama T, Li C, Banka S, Kogure A, Yazawa K, Shintani S.

BMC Complement Altern Med. 2014 Jan 17;14:29. doi: 10.1186/1472-6882-14-29.

9.

Root bark extracts of Juncus effusus and Paeonia suffruticosa protect salivary gland acinar cells from apoptotic cell death induced by cis-platinum (II) diammine dichloride.

Mukudai Y, Kondo S, Shiogama S, Koyama T, Li C, Yazawa K, Shintani S.

Oncol Rep. 2013 Dec;30(6):2665-71. doi: 10.3892/or.2013.2744. Epub 2013 Sep 20.

PMID:
24064583
10.

Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.

Mukudai Y, Kondo S, Fujita A, Yoshihama Y, Shirota T, Shintani S.

Cell Oncol (Dordr). 2013 Jun;36(3):233-45. doi: 10.1007/s13402-013-0131-y. Epub 2013 Mar 26.

PMID:
23529586
11.

The potential anticancer activity of extracts derived from the roots of Scutellaria baicalensis on human oral squamous cell carcinoma cells.

Sato D, Kondo S, Yazawa K, Mukudai Y, Li C, Kamatani T, Katsuta H, Yoshihama Y, Shirota T, Shintani S.

Mol Clin Oncol. 2013 Jan;1(1):105-111. Epub 2012 Aug 23.

12.

The root bark of Paeonia moutan is a potential anticancer agent in human oral squamous cell carcinoma cells.

Li C, Yazawa K, Kondo S, Mukudai Y, Sato D, Kurihara Y, Kamatani T, Shintani S.

Anticancer Res. 2012 Jul;32(7):2625-30.

PMID:
22753719
13.

Evaluation of anticancer activities of benzo[c]phenanthridine alkaloid sanguinarine in oral squamous cell carcinoma cell line.

Tsukamoto H, Kondo S, Mukudai Y, Nagumo T, Yasuda A, Kurihara Y, Kamatani T, Shintani S.

Anticancer Res. 2011 Sep;31(9):2841-6.

PMID:
21868527
14.

Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo.

Yasuda A, Kondo S, Nagumo T, Tsukamoto H, Mukudai Y, Umezawa K, Shintani S.

Oral Oncol. 2011 May;47(5):334-9. doi: 10.1016/j.oraloncology.2011.03.001. Epub 2011 Apr 2.

PMID:
21459660
15.

Binding of glyceraldehyde-3-phosphate dehydrogenase to the cis-acting element of structure-anchored repression in ccn2 mRNA.

Kondo S, Kubota S, Mukudai Y, Nishida T, Yoshihama Y, Shirota T, Shintani S, Takigawa M.

Biochem Biophys Res Commun. 2011 Feb 18;405(3):382-7. doi: 10.1016/j.bbrc.2011.01.034. Epub 2011 Jan 12.

PMID:
21236242
16.

A coding RNA segment that enhances the ribosomal recruitment of chicken ccn1 mRNA.

Mukudai Y, Kubota S, Eguchi T, Sumiyoshi K, Janune D, Kondo S, Shintani S, Takigawa M.

J Cell Biochem. 2010 Dec 15;111(6):1607-18. doi: 10.1002/jcb.22894.

PMID:
21053272
17.

Posttranscriptional regulation of chicken ccn2 gene expression by nucleophosmin/B23 during chondrocyte differentiation.

Mukudai Y, Kubota S, Kawaki H, Kondo S, Eguchi T, Sumiyoshi K, Ohgawara T, Shimo T, Takigawa M.

Mol Cell Biol. 2008 Oct;28(19):6134-47. doi: 10.1128/MCB.00495-08. Epub 2008 Aug 4.

18.

Novel transcription-factor-like function of human matrix metalloproteinase 3 regulating the CTGF/CCN2 gene.

Eguchi T, Kubota S, Kawata K, Mukudai Y, Uehara J, Ohgawara T, Ibaragi S, Sasaki A, Kuboki T, Takigawa M.

Mol Cell Biol. 2008 Apr;28(7):2391-413. doi: 10.1128/MCB.01288-07. Epub 2008 Jan 2.

19.

Nuclear protein TIA-1 regulates COL2A1 alternative splicing and interacts with precursor mRNA and genomic DNA.

McAlinden A, Liang L, Mukudai Y, Imamura T, Sandell LJ.

J Biol Chem. 2007 Aug 17;282(33):24444-54. Epub 2007 Jun 19.

20.

Different transcriptional strategies for ccn2/ctgf gene induction between human chondrocytic and breast cancer cell lines.

Eguchi T, Kubota S, Kawata K, Mukudai Y, Ohgawara T, Miyazono K, Nakao K, Kondo S, Takigawa M.

Biochimie. 2007 Mar;89(3):278-88. Epub 2007 Jan 3.

PMID:
17291666
21.
22.

Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3'-untranslated region interacting with a cellular protein in human chondrosarcoma cells.

Kondo S, Kubota S, Mukudai Y, Moritani N, Nishida T, Matsushita H, Matsumoto S, Sugahara T, Takigawa M.

Oncogene. 2006 Feb 16;25(7):1099-110.

PMID:
16247469
23.

Translational repression by the cis-acting element of structure-anchored repression (CAESAR) of human ctgf/ccn2 mRNA.

Kubota S, Mukudai Y, Moritani NH, Nakao K, Kawata K, Takigawa M.

FEBS Lett. 2005 Jul 4;579(17):3751-8.

24.

Regulation of chicken ccn2 gene by interaction between RNA cis-element and putative trans-factor during differentiation of chondrocytes.

Mukudai Y, Kubota S, Eguchi T, Kondo S, Nakao K, Takigawa M.

J Biol Chem. 2005 Feb 4;280(5):3166-77. Epub 2004 Nov 18.

26.

Cell-type-specific trans-activation of herpes simplex virus thymidine kinase promoter by the human T-cell leukemia virus type I Tax protein.

Kubota S, Mukudai Y, Hattori T, Eguchi T, Kondo S, Takigawa M.

DNA Cell Biol. 2001 Sep;20(9):563-8.

PMID:
11747607
27.

Role of chondroitin sulfate-hyaluronan interactions in the viscoelastic properties of extracellular matrices and fluids.

Nishimura M, Yan W, Mukudai Y, Nakamura S, Nakamasu K, Kawata M, Kawamoto T, Noshiro M, Hamada T, Kato Y.

Biochim Biophys Acta. 1998 Mar 12;1380(1):1-9.

PMID:
9545510
28.

Bone morphogenetic protein signaling is required for maintenance of differentiated phenotype, control of proliferation, and hypertrophy in chondrocytes.

Enomoto-Iwamoto M, Iwamoto M, Mukudai Y, Kawakami Y, Nohno T, Higuchi Y, Takemoto S, Ohuchi H, Noji S, Kurisu K.

J Cell Biol. 1998 Jan 26;140(2):409-18.

29.

Involvement of alpha5beta1 integrin in matrix interactions and proliferation of chondrocytes.

Enomoto-Iwamoto M, Iwamoto M, Nakashima K, Mukudai Y, Boettiger D, Pacifici M, Kurisu K, Suzuki F.

J Bone Miner Res. 1997 Jul;12(7):1124-32.

Supplemental Content

Loading ...
Support Center